Advertisement

End-Stage Liver Disease and Variceal Bleeding

  • Autumn Graham
  • Andrew C. MeltzerEmail author
Chapter

Abstract

Cirrhosis occurs when damage to the liver results in scar tissue (hepatic fibrosis), affecting liver function. By the time cirrhosis is diagnosed or suspected based on stigmata of chronic liver disease (e.g., spider angiomas, jaundice, pruritis, palmar erythema) and laboratory abnormalities, approximately 30–40% of patients will have varices. Of those without varices at the time of diagnosis, another 10–15% will develop varices each year. Despite its probable safety based on small retrospective series, the decision to place an NGT for aspiration or lavage requires a careful assessment of the potential risks (e.g., bleeding, pain, aspiration, unclear prognostic and outcome value) and benefits (e.g., localization of bleed and assessment of active bleeding) of the procedure. Gastrointestinal bleeding in patients with cirrhosis is common and carries a high mortality rate of approximately 15–30%. Risk factors associated with early re-bleeding and poor outcomes include severe initial bleeding as defined by a hemoglobin less than 8 g/dL, gastric variceal bleeding, thrombocytopenia, encephalopathy, alcohol-related cirrhosis, large varices, and active bleeding during endoscopy. Antibiotics have a proven benefit in variceal bleeding with decreased morbidity and mortality. Vasoactive medications such as terlipressin a synthetic vasopressin not available in the United States, octreotide, and somatostatin have all been studied and found to have varied benefits in the treatment of variceal bleeding.

Keywords

Liver disease Gastrointestinal bleeding Variceal bleeding Varices Cirrhosis 

References

  1. 1.
    Kamath P, Shah V. Overview of cirrhosis. Chap 74: Sleisenger and Fordtran's gastrointestinal and liver disease. 1254–1260.e1.Google Scholar
  2. 2.
    Nable J, Graham A. Gastrointestinal bleeding. Emerg Med Clin. 2016;34(2):309–25.CrossRefGoogle Scholar
  3. 3.
    Turan F, Casu S, Hernandez-Gea V, Garcia-Pagan J. Variceal and other portal hypertension related bleeding. Best Prac Res Clin Gastro. 2013;27:649–64.CrossRefGoogle Scholar
  4. 4.
    Satapathy S, Sanyal A. Non-endoscopic management strategies for acute esophagogastric variceal bleeding. Gastroenterol Clin N Am. 2014;43(4):819–33.CrossRefGoogle Scholar
  5. 5.
    Garcia-Tsao G, Sanyal A, Grace N, Carey W. Practice guidelines Committee of the American Association for the Study of liver diseases and the practice parameters Committee of the American College of Gastroenterology. Practice guidelines: Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Am J Gastroenterol. 2007;102:2086–102.CrossRefGoogle Scholar
  6. 6.
    Haq I, Tripathi D. Recent advances in the management of variceal bleeding. Gastroenterology Rep. 2017;5(2):113–26.CrossRefGoogle Scholar
  7. 7.
    Lopez-Torres A, Waye JD. The safety of intubation in patients with esophageal varices. Am J Dig Dis. 1973;18(12):1032–4.CrossRefGoogle Scholar
  8. 8.
    Ritter D, Rettke S, Hughes R, Burritt M, Sterioff S, Ilstrup D. Placement of nasogastric tubes and esophageal stethoscopes in patients with documented esophageal varices. Anesth Analg. 1988;67:283–5.PubMedGoogle Scholar
  9. 9.
    Reverter E, Tandon P, Augustin S, Turon F, Casu S, et al. A MELD – based model to determine risk of mortality among patients with acute variceal bleeding. Gastroenterology. 2014;146:412–9.CrossRefGoogle Scholar
  10. 10.
    Iino C, Shimoyama T, Igarashi T, Aihara T, Ishii K, Sakamoto J, Tono H, Fukuda S. Usefulness of the Glasgow Blatchford score to predict 1 week mortality in patients with esophageal variceal bleeding. Eur J Gastroenterol Hepatol. 2017;29(5):547–51.CrossRefGoogle Scholar
  11. 11.
    Wells M, Chande N, Adams P, et al. Meta-analysis: vasoactive medications for the management of acute variceal bleeds. Aliment Pharmacol Ther. 2012;35:1267–78.CrossRefGoogle Scholar
  12. 12.
    Fernandez J, Ruiz DA, Gomez C, Durandez R, Serradilla R, Guarner C, Planas R, Arroyo V, Navasa M. Norfloxacin vs ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage. Gastroenterology. 2006;131:1049–56.CrossRefGoogle Scholar
  13. 13.
    Gotzsche P, Hrobjartsson A. Somatostatin analogues for acute bleeding oesophageal varices. Cochrane Database Syst Rev. 2008;3:CD000193.Google Scholar
  14. 14.
    Villanueva C, Colomo A, Bosch A, et al. Transfusion strategies for acute upper gastrointestinal bleeding. N Engl J Med. 2013;368:11–21.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Department of Emergency MedicineMedStar Washington Hospital Center, MedStar Georgetown University HospitalWashington, DCUSA
  2. 2.Department of Emergency MedicineGeorge Washington University School of Medicine & Health SciencesWashington, DCUSA

Personalised recommendations